简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-12-28 15:00 Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
2023-12-28 09:29 CCM Biosciences Announces Launch of 5Prime Sciences Business Unit
2023-12-25 09:55 Fujirebio Expands Its Alzheimer’s Disease Test Menu With the Much Awaited and Fully Automated Lumipulse® G pTau 217 Plasma Assay for Research Use Only (RUO)
2023-12-22 11:14 Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies
2023-12-21 19:18 Hyperice Advances Performance for Elite Athletes and Everyday Consumers with the Introduction of Normatec
2023-12-20 16:01 Biocytogen Enters into Multi-Target Antibody Agreement With Neurocrine Biosciences
2023-12-19 12:04 Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines
2023-12-19 10:22 DENTALIS Animal Health Awarded with VOHC Seal
2023-12-19 10:14 Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors
2023-12-18 12:14 Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2023-12-15 14:03 Estée Lauder Announces New Skin Longevity Initiative, The Next Frontier of Beauty
2023-12-15 11:01 QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development
2023-12-15 10:10 Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth
2023-12-15 09:39 Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay
2023-12-14 15:18 Rapid Medical™ Announces Japanese Approval and Exclusive Partnership With Kaneka for TIGERTRIEVER–The World’s Only Adjustable Thrombectomy Device
2023-12-14 14:10 AOP Health Receives Market Authorization for Landiolol in Canada
2023-12-14 09:41 WHOOP Announces Its “Year In Review” Celebrating That 2023 Was the Year Human Performance Became a Lifestyle
2023-12-13 14:17 Suzhou OSAI Biopharma Announces Positive Phase III Clinical Trial Results for Lactobacillus Crispatus Live Bacteria Capsule, Significantly Reducing Recurrence of Gynecological Infections
2023-12-13 13:34 Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production
2023-12-13 13:24 Armis Named Leader in Three Q4 2023 Quadrant SPARK Matrix™ Reports